Skip to main content
$141.22 $3.29 (2.4%)

04:00 PM EDT on 09/28/22

Alexandria Real Estate Equities, Inc. (NYSE:ARE)

CAPS Rating: 4 out of 5

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Current Price $141.22 Mkt Cap $22.5B
Open $139.24 P/E Ratio 52.97
Prev. Close $141.22 Div. (Yield) $4.72 (3.4%)
Daily Range $138.08 - $142.26 Volume 982,308
52-Wk Range $130.00 - $224.95 Avg. Daily Vol. 852,792

Caps

How do you think NYSE:ARE will perform against the market?

Add Stock to CAPS Watchlist

All Players

98 Outperform
53 Underperform
 

All-Star Players

22 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ARE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFMattyA (99.89)
Submitted September 17, 2013

Alexandria Real Estate Equities (ARE) is the largest “life science” real estate company, serving major pharmaceutical, biotech, and medical sciences industries. At the end of 2012, ARE owned 178 properties, covering about 17 million rent-able square… More

Ewok82 (27.44)
Submitted May 25, 2009

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

Recent Community Commentary

Read the most recent pitches from players about ARE.

Recs

0
Member Avatar SanFranFan (< 20) Submitted: 6/24/2022 2:03:00 AM : Outperform Start Price: $138.00 NYSE:ARE Score: +5.19

I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.

Recs

0
Member Avatar DaytradingStars (35.39) Submitted: 12/3/2021 2:23:15 AM : Outperform Start Price: $200.72 NYSE:ARE Score: -10.33

63% 13% result

Recs

0
Member Avatar RowdyCat (49.45) Submitted: 2/9/2020 11:40:48 AM : Outperform Start Price: $158.77 NYSE:ARE Score: -22.91

This pick gets exposure to the biotech/pharma industries without investment in a specific company. Rather, ARE is a REIT that builds out laboratory space for up and coming companies.

Leaderboard

Find the members with the highest scoring picks in ARE.

Score Leader

SSPX3

SSPX3 (38.95) Score: +253.20

The Score Leader is the player with the highest score across all their picks in ARE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SSPX3 38.95 5/14/2009 Outperform NS $20.92 +575.16% +321.96% +253.20 0 Comment
czarl 72.30 5/27/2009 Outperform NS $23.84 +492.25% +309.44% +182.81 0 Comment
TraderJFH 97.76 7/22/2009 Outperform 1Y $25.11 +462.45% +288.87% +173.58 0 Comment
crabbucket1 < 20 5/4/2009 Outperform 3M $23.83 +492.57% +322.79% +169.78 1 Comment
mitchiemono 78.64 4/27/2009 4/24/2010 Outperform 3Y $24.39 +478.97% +336.97% +142.00 0 Comment
NSHanlon 59.83 4/27/2009 Outperform 3Y $24.39 +478.97% +336.97% +142.00 0 Comment
SSPXXX 71.58 6/8/2009 Outperform 5Y $27.18 +419.49% +298.94% +120.54 0 Comment
Lance03 < 20 3/9/2009 Outperform NS $21.34 +561.66% +454.88% +106.78 0 Comment
mamabourne 97.87 8/7/2008 Underperform 3M $69.17 +104.16% +198.05% +93.89 0 Comment
brgr1 < 20 8/27/2008 Underperform 1Y $68.51 +106.12% +199.71% +93.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARE.